For citations:
Voloshin S.V., Linnikov S.Yu., Garifullin A.D., Kuzyaeva A.A., Shmidt A.V., Kuvshinov A.Yu., Bogdanov A.N., Mikhileva M.A., Martynkevich I.S., Zenina M.N., Sidorkevich S.V. The role of pomalidomide in treatment of relapse and refractory multiple myeloma. Oncohematology. 2022;17(1):26-36. (In Russ.) https://doi.org/10.17650/1818-8346-2022-17-1-26-36
Email this article 